Advertisement

Applications of Next Generation Sequencing in Haematological Disorders—Indian Status: Updates from ISHBT 2018

  • Madhavi Maddali
  • Poonkuzhali BalasubramanianEmail author
Review Article
  • 15 Downloads

Abstract

Research in India based on next generation sequencing (NGS) has been plentiful over the past few years. Significant progress in research both in benign and malignant haematology can be attributed to this technique. It has now progressed to both diagnostic and a theranostic modality in many areas of not only haematology but also other medical specialities. Papers presented at the annual conference of the Indian Society of Haematology and Blood Transfusion, ISHBT (Haematocon 2018) highlighted a snapshot of the research activities using NGS that are ongoing in various academic and other centres. This review summarizes the salient findings of the original research abstracts presented. The papers are divided into two broad subsections of non-malignant and malignant haematology.

Keywords

Next Generation Sequencing (NGS) Targeted sequencing Benign haematology Malignant haematology 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors have no conflict of interest to disclose.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Jamwal M, Aggarwal S, Sharma P, Bansal D, Malhotra P, Maitra A, Das R (2018) A next generation sequencing based approach to elucidate the clinical and genetic spectrum of uncommon congenital anemias. Indian J Hematol Blood Transfus 34(suppl 1):S5Google Scholar
  2. 2.
    More TA, Kedar P, Warang P, Dongerdiye R, Devendra R, Madkaikar M (2018) First report of dysfunctional mechanosensitive Piezo ion channel protein (PIEZO1) associated with hereditary xerocytosis in India. Indian J Hematol Blood Transfus 34(suppl 1):S23Google Scholar
  3. 3.
    Jajodia E, Fouzia NA, Abraham A, Korula A, Devasia AJ, Srivastava A, Mathews V, George B, Edison ES, Shaji RV (2018) Molecular diagnosis of RBC membranopathy and enzymopathy by long amplicon PCR based next-generation sequencing (LAP-NGS). Indian J Hematol Blood Transfus 34(suppl 1):S76Google Scholar
  4. 4.
    Senthil Kumar G, Arun KA, Jajodia E, Jain N, George B, Srivastava A, Mathews V, Edison ES, Shaji RV (2018) A novel, NGS based method for the detection of haemoglobin variants. Indian J Hematol Blood Transfus 34(suppl 1):S113Google Scholar
  5. 5.
    Joshi G, Janet NB, Thenral SG, Sakthivel SM, Srivastava V, Srivastava A, Ramprasad VL, George B, Shaji RV (2018) Exome sequencing reveals complex genetic subtypes of Fanconi anaemia in Indian population. Indian J Hematol Blood Transfus 34(suppl 1):S29Google Scholar
  6. 6.
    Maddali M, Rajkumar SV, Sankari Devi G, Mathews V, George B, Srivastava A, Edison ES, Shaji RV (2018) A long amplicon PCR—next generation sequencing (LAP-NGS) method for efficient and cost-effective molecular diagnosis of haemophilia A and haemophilia B. Indian J Hematol Blood Transfus 34(suppl 1):S25Google Scholar
  7. 7.
    Shanbhag S, Soni P, Deshpande R, Yadav S, Shetty S (2018) Unusual clinical and laboratory indicators in two cases leading to the diagnosis of Glanzmanns thrombasthenia (GT). Indian J Hematol Blood Transfus 34(suppl 1):S138Google Scholar
  8. 8.
    Kawankar NK, Kulkarni B, Shetty S (2018) Identification of novel mutations in RASGRP2 gene in patients with unclassified platelet function disorder. Indian J Hematol Blood Transfus 34(suppl 1):S140Google Scholar
  9. 9.
    Kamalanathan N, Arun KA, Korula A, Fouzia NA, Abraham A, George B, Mathews V, Edison ES (2018) Molecular diagnosis of primary immunodeficiency diseases. Indian J Hematol Blood Transfus 34(suppl 1):S159Google Scholar
  10. 10.
    Arun KA, Senthamizhselvi A, Suresh H, Edison ES, Korula A, Fouzia NA, George B, Shaji RV, Mathews V, Balasubramanian P (2018) Screening of genetic variants in congenital neutropenia by next generation sequencing. Indian J Hematol Blood Transfus 34(suppl 1):S31Google Scholar
  11. 11.
    Bhanshe P, Patkar N, Kodgule R, Jain H, Bagal N, Sangar M, Khattry N, Subramanian PG, Gujral D, Ghoghale S (2018) Ultradeep next generation sequencing (NGS) based measurable residual disease (MRD) assessment in NPM1 mutated acute myeloid leukemia (AML) is the most important predictor of outcome. Indian J Hematol Blood Transfus 34(suppl 1):S14Google Scholar
  12. 12.
    Naeem F, Raval G, Kodgule R, Chaudhary S, Joshi S, Patkar N (2018) Ultradeep error corrected next generation sequencing (NGS) of CEBPA mutations in acute myeloid leukemia. Indian J Hematol Blood Transfus 34(suppl 1):S261Google Scholar
  13. 13.
    Ghai SR, Raval G, Kodgule R, Bhanshe P, Choudhary S, Joshi S, Tembhare P, Gujral S, Subramanian PG, Patkar N (2018) NUP98-NSD1 gene rearrangement in acute myeloid leukemia (AML)—report of two cases detected by targeted RNA sequencing. Indian J Hematol Blood Transfus 34(suppl 1):S15Google Scholar
  14. 14.
    Shaikh AF, Raval G, Kodgule R, Choudhary S, Joshi S, Bhanshe P, Tembhare P, Subramanian PG, Gujral S, Patkar N (2018) A laboratory developed targeted RNA sequencing assay for identification of fusion genes in BCR-ABL1 like precursor B-lineage acute lymphoblastic leukemia (BCR-ABL1 like BCP-ALL). Indian J Hematol Blood Transfus 34(suppl 1):S16Google Scholar
  15. 15.
    Soni VR, Raval G, Kodgule R, Chaudhary S, Joshi S, Bhanshe P, Subramanium PG, Tembhare P, Gujral D, Patkar N (2018) Development of an in-house low cost RNA sequencing panel for detection of myeloid neoplasms with clonal eosinophilia. Indian J Hematol Blood Transfus 34(suppl 1):S327Google Scholar
  16. 16.
    Chopra A, Verma D, Singh J, Bakhshi S, Seth R, Kumar R (2018) Comprehensive analysis of lncRNAome in immature T-ALL. Indian J Hematol Blood Transfus 34(suppl 1):S243Google Scholar
  17. 17.
    Benjamin ESB, Bharathi MR, Senthamizhselvi A, Abraham A, George B, Srivastava A, Mathews V, Balasubramanian P (2018) BCR-ABL kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib. Indian J Hematol Blood Transfus 34(suppl 1):S39Google Scholar
  18. 18.
    Tripthi B, Mehta A, Chaudhary S, Joshi S, Raval G, Kodgule R, Gujral S, Subramanian PG, Tembhare P, Patkar N (2018) Ultra deep error corrected next generation sequencing (NGS) of ABL1 kinase domain mutation (KDM) in BCR-ABL1 positive malignancies. Indian J Hematol Blood Transfus 34(Suppl 1):S301Google Scholar
  19. 19.
    Maddali M, Suresh H, Kulkarni UP, Devasia AJ, Fouzia NA, Korula A, Abraham A, George B, Srivastava A, Shaji RV, Mathews V, Balasubramanian P (2018) Molecular characterization of triple negative myeloproliferative neoplasms (TN-MPN) by targeted next generation sequencing. Indian J Hematol Blood Transfus 34(Suppl 1):S332Google Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2019

Authors and Affiliations

  1. 1.Department of HaematologyChristian Medical College and HospitalVelloreIndia

Personalised recommendations